Affitope-PD03 (AFFiRiS)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAffitope-PD03 (AFFiRiS)
Drug Alias NamePD-03AAFFITOPE-PD03A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsSynuclein alpha inhibitors
TargetsSynuclein alpha
Therapy Area/IndicationsNeurodegenerative DiseasesParkinson DiseaseMultiple System Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaFrance
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAffiris Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffiris Ag
Active IndicationsN/A
Inactive IndicationsNeurodegenerative DiseasesParkinson DiseaseMultiple System Atrophy

Other Information

ATC CodeN/A
Related LinksN/A